| 000 | 01340 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514033608.0 | ||
| 264 | 0 | _c20020712 | |
| 008 | 200207s 0 0 ger d | ||
| 022 | _a0012-0472 | ||
| 024 | 7 |
_a10.1055/s-2002-31941 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDissemond, J | |
| 245 | 0 | 0 |
_a[Pimecrolimus (SDZ ASM 981). Current state of research]. _h[electronic resource] |
| 260 |
_bDeutsche medizinische Wochenschrift (1946) _cMay 2002 |
||
| 300 |
_a1199-203 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDermatologic Agents _xadverse effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 |
_aSkin Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGoos, M | |
| 700 | 1 | _aWagner, S N | |
| 773 | 0 |
_tDeutsche medizinische Wochenschrift (1946) _gvol. 127 _gno. 22 _gp. 1199-203 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2002-31941 _zAvailable from publisher's website |
| 999 |
_c11932392 _d11932392 |
||